205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-14.65%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-17.85%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-18.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-14.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-13.94%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.77%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.77%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.76%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
7.68%
Dividend growth under 50% of NXPI's 17.92%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-26.17%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-45.60%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
92.58%
10Y revenue/share CAGR at 50-75% of NXPI's 184.07%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
35.39%
5Y revenue/share CAGR under 50% of NXPI's 77.69%. Michael Burry would suspect a significant competitive gap or product weakness.
43.56%
3Y revenue/share CAGR at 75-90% of NXPI's 55.65%. Bill Ackman would expect new product strategies to close the gap.
131.20%
10Y OCF/share CAGR under 50% of NXPI's 528.01%. Michael Burry would worry about a persistent underperformance in cash creation.
15.09%
Below 50% of NXPI's 92.11%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
19.89%
3Y OCF/share CAGR under 50% of NXPI's 42.94%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
812.98%
Net income/share CAGR 1.25-1.5x NXPI's 695.77%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
520.08%
5Y net income/share CAGR above 1.5x NXPI's 26.34%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
88.83%
Below 50% of NXPI's 584.85%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
63.37%
Below 50% of NXPI's 579.71%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
53.31%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
68.54%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
487.06%
Dividend/share CAGR of 487.06% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
99.82%
Dividend/share CAGR of 99.82% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
37.51%
Below 50% of NXPI's 138.25%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-7.11%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
14.68%
Inventory growth well above NXPI's 12.71%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.41%
Asset growth above 1.5x NXPI's 1.29%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.26%
Under 50% of NXPI's 5.84%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
14.39%
Debt growth far above NXPI's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
0.70%
We increase R&D while NXPI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.46%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.